Article
Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention
9 Feb 2017
Abstract excerpt
INTRODUCTION: Human papillomavirus (HPV)-related cancers can be averted by type-specific vaccination (primary prevention) and/or through detection and ablation of precancerous cervical lesions (secondary prevention). This review presents current challenges to cervical cancer screening programs, focusing on recent molecular advances in HPV testing and potential improvements on risk stratification. Areas covered:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
